Related references
Note: Only part of the references are listed.Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding
An Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Matrix Metalloproteinases and Cancer - Roles in Threat and Therapy
Lalita Yadav et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Anoikis molecular pathways and its role in cancer progression
Paolo Paoli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis
Krzysztof Fink et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2012)
Interaction of tumor cells with the microenvironment
Hendrik Ungefroren et al.
CELL COMMUNICATION AND SIGNALING (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
MT-MMPs as regulators of vessel stability associated with angiogenesis
Nor Eddine Sounni et al.
FRONTIERS IN PHARMACOLOGY (2011)
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
Elena I. Deryugina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
Dimitra Bourboulia et al.
SEMINARS IN CANCER BIOLOGY (2010)
Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck
Ajay Kumar Chaudhary et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: Developing a structure-activity relationship
Yi-Long Yan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies
Ch. Gialeli et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Matrix metalloproteinases at cancer tumor-host interface
Agnes Noel et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
The collagen family members as cell adhesion proteins
Jyrki Heino
BIOESSAYS (2007)
Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells
Sara A. Illman et al.
JOURNAL OF CELL SCIENCE (2006)
Recent advances in MMP inhibitor design
JF Fisher et al.
CANCER AND METASTASIS REVIEWS (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Tetracyclines: Nonantibiotic properties and their clinical implications
AN Sapadin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Recent advances in understanding the mechanism of action of bisphosphonates
Fraser P. Coxon et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
The collagen superfamily: from the extracellular matrix to the cell membrane
S Ricard-Blum et al.
PATHOLOGIE BIOLOGIE (2005)
ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and, β-catenin translocation
T Maretzky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Matrix metalloproteinase inhibitors as anticancer therapeutics
F Mannello et al.
CURRENT CANCER DRUG TARGETS (2005)
Matrix metalloproteinases as therapeutic targets in cancer
P Vihinen et al.
CURRENT CANCER DRUG TARGETS (2005)
The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells
DV Rozanov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Collagens, modifying enzymes and their mutations in humans, flies and worms
J Myllyharju et al.
TRENDS IN GENETICS (2004)
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
AR Folgueras et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
Collagens -: structure, function, and biosynthesis
K Gelse et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells
TN Mitropoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis
M Hangai et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Protease degradomics:: A new challenge for proteomics
C López-Otin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Matrix metalloproteinases in cancer:: Prognostic markers and therapeutic targets
P Vihinen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
AP-1-glucocorticoid receptor crosstalk taken to a higher level
M Karin et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Share Paper
